Detalhe da pesquisa
1.
Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel.
Ann Emerg Med
; 76(4): 470-485, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732375
2.
Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.
Curr Cardiol Rep
; 19(12): 124, 2017 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29064044
3.
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.
J Thromb Thrombolysis
; 41(1): 206-32, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780747
4.
Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatment.
J Thromb Thrombolysis
; 39(3): 295-303, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25605686
5.
Reply to "Key Points to Consider When Evaluating Andexxa for Formulary Addition".
Neurocrit Care
; 33(1): 323-326, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32572822
6.
A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents.
J Thromb Thrombolysis
; 37(3): 271-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23653171
7.
Identifying, monitoring and reducing preventable major bleeds in the hospital setting.
J Thromb Thrombolysis
; 36(1): 7-13, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23054465
8.
Cost-of-Illness Analysis of Long-Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry.
J Am Heart Assoc
; 11(20): e027514, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250664
9.
Potential Drug Interactions between Recombinant Interleukin-2 and Direct Oral Anticoagulants: Indirect Evidence from In Vivo Animal Studies.
Hamostaseologie
; 40(5): 679-686, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325520
10.
Stroke prevention in patients with atrial fibrillation and renal dysfunction.
Stroke
; 45(8): 2497-505, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24968930
11.
Thrombophilia Issue.
J Pharm Pract
; 27(3): 224-6, 2014 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24739278
12.
Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Hosp Pract (1995)
; 46(1): 5-15, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29171776
13.
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism.
Clin Appl Thromb Hemost
; 24(4): 575-582, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29514466
14.
Venous thromboembolism: role of pharmacists and managed care considerations.
Am J Manag Care
; 23(20 Suppl): S391-S398, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29297662
15.
Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
Am J Med
; 130(9): 1015-1023, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28502818
16.
Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism.
Am J Med
; 130(10): 1137-1143, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687262
17.
Reversing factor Xa inhibitors - clinical utility of andexanet alfa.
J Blood Med
; 8: 141-149, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28979172
18.
European Union-28: An annualised cost-of-illness model for venous thromboembolism.
Thromb Haemost
; 115(4): 800-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26607486
19.
All-cause mortality and use of antithrombotics within 90 days of discharge in acutely ill medical patients.
Thromb Haemost
; 114(4): 685-94, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26202514
20.
External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
Thromb Haemost
; 112(4): 692-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24990708